key: cord-0828951-m7y07btx authors: Hellmann, Fernando; Williams-Jones, Bryn; Garrafa, Volnei title: COVID-19 and Moral Imperialism in Multinational Clinical Research date: 2020-04-29 journal: Arch Med Res DOI: 10.1016/j.arcmed.2020.04.017 sha: 0c6cfd13c50536e202adcaf0ea15c591f37cd9ca doc_id: 828951 cord_uid: m7y07btx Abstract A TV debate in April 2020 between two French doctors regarding the benefits of testing a coronavirus vaccine in Africa where there are no masks or treatments available has led to international criticism. This case highlights a problematic ethical double standard in multinational clinical research: trials that would be considered unethical in high income countries (e.g., placebo-controlled where there is an existing treatment) are nonetheless justified in low-and-middle-income countries because the existing standards of care are less (i.e., no access to a treatment). Underlying this ethical double standard in some multinational clinical trials is a moral imperialism and persistent colonialist thinking that must be rejected. international criticism. This case highlights a problematic ethical double standard in multinational clinical research: trials that would be considered unethical in high income countries (e.g., placebocontrolled where there is an existing treatment) are nonetheless justified in low-and-middle-income countries because the existing standards of care are less (i.e., no access to a treatment). Underlying this ethical double standard in some multinational clinical trials is a moral imperialism and persistent colonialist thinking that must be rejected. Key Words: Ethics, Research Design, Clinical Trials, COVID-19, low-and-middle-income countries, Colonialism. In early April 2020, two French doctors were accused of racism following a TV debate in which they discussed the pertinence of testing a COVID-19 vaccine in Africa (1). One doctor asked: "If I can be provocative, shoul dont we be doing this study in Africa, where there are no masks, no treatments, no resuscitation, a bit like it is done elsewhere for some studies on AIDS or in prostitutes: we try things because we know they are highly exposed. What do you think?" The other doctor agreed that such a trial was warranted. What these two doctors proposed is known as a double standard, i.e., to conduct research in low-and-middle-income countries (LMIC) that would not be ethically acceptable or permitted in a high-income country (HIC) because of different standards of care, e.g., access to existing therapies, or in this case, protective measures such as masks and gloves. Although provocative and shocking to many, the exchange between the French doctors -who were forced to publicly apologize -points to situations that have occurred in the past and continue to occur today in LMIC (2) . Further, it highlights a persistent moral imperialism and colonialist thinking in some multinational clinical trials that leads HIC researchers to imagine that widely accepted research ethics Lingering prejudices from 19 th and 20 th Century colonial expansion help to perpetuate a status quo relationship between HIC and LMIC. Social inequity is materialized in numerous countries (LMIC, but also HIC) through a lack of universal access to proper health care, but is still wrongly understood by some bioethicists and by clinical researchers as a "local standard" that researchers must "live with". Worse, existing ethical guidelines continue to accommodate clinical trials methods in LMIC that would, in HIC, be considered unethical. In this context, the provocative hypothesis advanced on French TV regarding COVID-19 vaccine research in Africa -i.e., on populations who do not have access to protective measures such as masks or gloves that would be the norm in HIC -must be seen for what it is, a demonstration that the moral imperialism and colonial frameworks still exist and continue to be articulated in the outsourcing of clinical trials to LMIC. Coronavirus : des spécialistes français s'excusent après leurs propos sur un test de vaccin en Afrique Moral imperialism and multi-centric clinical trials in peripheral countries Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries The best possible intentions" testing prophylactic approaches on humans in developing countries Imperialism, race, and therapeutics: the legacy of medicalizing the "colonial body The Standard of Care Debate: Against the Myth of an "International Consensus Opinion